Short answer
QuidelOrtho Corp (QDEL) filed its Q2 2026 10-Q quarterly report on Aug 7, 2026 for the quarter ended Jun 28, 2026. Quarterly revenue was $631M (up 2.8% year over year) with net income of −$93M.
Q2 2026 key financials · XBRL
- Revenue
- $631M
- +2.8% YoY · +1.8% QoQ
- Net income
- −$93M
- +63.6% YoY · −1.2% QoQ
- Operating margin
- -3.5%
- EPS (diluted)
- −$1.36
- +64.0% YoY · −0.7% QoQ
Source: XBRL data from the QuidelOrtho Corp (QDEL) Q2 2026 10-Q on SEC EDGAR. USD.
QuidelOrtho Corp Q2 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $630.9M, up 3% YoY from $613.9M
- Cost of sales margin 56.7% vs 55.2% YoY
- Best product line Point of Care $108.2M, up 16% YoY
- Worst product line Molecular Diagnostics $1.6M, down 71% YoY
- Outlook: weaker respiratory season may continue pressuring flu and COVID-19 testing through second half 2026
Risk Factors
- No material changes to previously disclosed risk factors from the 2025 Annual Report
- Regulatory compliance risk: no new developments identified in the quarterly filing
- Operational risk: existing Annual Report risks remain relevant without quarterly updates
- Financial risk: existing liquidity and debt risks remain unchanged from the Annual Report
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other QuidelOrtho Corp quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.